Rhinostat Offers Freedom From Decongestant Nasal Sprays
Rhinostat Offers Freedom From Decongestant Nasal Sprays
Rhinitis Medicamentosa (RM) is a form of chemically induced nasal congestion associated with the use of topical decongestant nasal sprays. The challenge in treating RM patients is the severe congestion which can persist for 4-7 days after the sprays are abruptly withdrawn. Rhinostat allows RM patients to maintain normal nasal airflow as they are gradually weaned from the decongestant nasal sprays.
The cornerstone of treating RM is always the same; patients must discontinue their use of the decongestant sprays. Very few patients are capable of tolerating the restricted nasal airflow associated with conventional protocols, which is why the treatment of RM patients often fails. To preserve normal airflow, Rhinostat users wean themselves in a precise and gradual manner over a 3-5 week period (taper titration.)
Rhinostat is the Rhinitis Medicamentosa Company. Helping RM patients is our only business since 1999. We work directly with RM patients as well as their physician’s office. No prescription is required, and Rhinostat offers an unconditional 100% money back guarantee. We ship to more than 70 countries worldwide via the US Postal Service. Orders are discretely packaged and ship within one business day.
* There are more than 2.4 million search engine queries per year in the USA related to RM. The USA accounts for approximately 4.4% of the world’s population. Topical decongestants are sold over-the-counter in more than 150 countries.